Doerr HW - Search Results

1

Possible hidden hazards of mass vaccination against new influenza A/H1N1: have the cardiovascular risks been adequately weighed?

Bhakdi S, Lackner K, Doerr HW. Bhakdi S, et al. Among authors: doerr hw. Med Microbiol Immunol. 2009 Nov;198(4):205-9. doi: 10.1007/s00430-009-0130-9. Med Microbiol Immunol. 2009. PMID: 19851782

2

Therapeutic vaccination in chronic hepatitis B--approaches, problems, and new perspectives. Preface.

Gerlich W, Doerr HW. Gerlich W, et al. Among authors: doerr hw. Med Microbiol Immunol. 2015 Feb;204(1):1-4. doi: 10.1007/s00430-014-0368-8. Med Microbiol Immunol. 2015. PMID: 25550114 No abstract available.

3

Fighting cytomegalovirus-caused diseases: the immunologic approach.

Doerr HW. Doerr HW. Med Microbiol Immunol. 2016 Dec;205(6):511-512. doi: 10.1007/s00430-016-0474-x. Med Microbiol Immunol. 2016. PMID: 27550158 No abstract available.

4

Eradication of measles: remaining challenges.

Holzmann H, Hengel H, Tenbusch M, Doerr HW. Holzmann H, et al. Among authors: doerr hw. Med Microbiol Immunol. 2016 Jun;205(3):201-8. doi: 10.1007/s00430-016-0451-4. Epub 2016 Mar 2. Med Microbiol Immunol. 2016. PMID: 26935826 Free PMC article. Review.

5

Will the next human influenza pandemic be caused by the virus of the avian flu A/H5N1? Arguments pro and counter.

Doerr HW, Varwig D, Allwinn R, Cinatl J. Doerr HW, et al. Med Microbiol Immunol. 2006 Jun;195(2):45-7. doi: 10.1007/s00430-005-0008-4. Med Microbiol Immunol. 2006. PMID: 16411135 Free PMC article.

6

Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans?

Allwinn R, Geiler J, Berger A, Cinatl J, Doerr HW. Allwinn R, et al. Among authors: doerr hw. Med Microbiol Immunol. 2010 May;199(2):117-21. doi: 10.1007/s00430-010-0143-4. Epub 2010 Feb 17. Med Microbiol Immunol. 2010. PMID: 20162304

7

Laboratory diagnosis of influenza--virology or serology?

Allwinn R, Preiser W, Rabenau H, Buxbaum S, Stürmer M, Doerr HW. Allwinn R, et al. Among authors: doerr hw. Med Microbiol Immunol. 2002 Dec;191(3-4):157-60. doi: 10.1007/s00430-002-0137-y. Epub 2002 Aug 30. Med Microbiol Immunol. 2002. PMID: 12458351

8

Vaccination against infectious diseases: what is promising?

Doerr HW, Berger A. Doerr HW, et al. Med Microbiol Immunol. 2014 Dec;203(6):365-71. doi: 10.1007/s00430-014-0346-1. Epub 2014 Jul 27. Med Microbiol Immunol. 2014. PMID: 25064610 Review.

9

Preventing vertical virus infections: the role of serologic screening of pregnant women.

Berger A, Doerr HW. Berger A, et al. Among authors: doerr hw. Med Microbiol Immunol. 2018 Nov;207(5-6):249-253. doi: 10.1007/s00430-018-0549-y. Epub 2018 Jul 3. Med Microbiol Immunol. 2018. PMID: 29971491 Review.

10

Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patients.

Bickel M, Lais C, Wieters I, Kroon FP, Doerr HW, Herrmann E, Brodt HR, Jung O, Allwinn R, Stephan C. Bickel M, et al. Among authors: doerr hw. Scand J Infect Dis. 2014 Sep;46(9):656-9. doi: 10.3109/00365548.2014.922695. Epub 2014 Jul 8. Scand J Infect Dis. 2014. PMID: 25004089

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results